Further observations arising from MEDACT Seminar on determining health effects of
Depleted Uranium.
It must be borne in mind that compared with the most of the likely exposures from
military use of DU, the Uranium burdens in lung and TBLNs were monstrously high in this
study; radiation doses to TBLNs were of the order of 1,000,000 times natural background
at the end of the 5 year exposure, and doubled over the ensuing 6½ years.
Unsurprisingly lymph nodes suffered extensive destruction:
1 Leach LJ Elliott AM et el A five year inhalation study with natural uranium dioxide dust. 1: retention and
biological effect in the monkey dog and rat. Health Physics 1970 18 599-612
2 Leach J L, Yuile C L, et al A five year inhalation study with natural uranium dioxide dust.
II Postexposure retention and biologic effects in the monkey, dog and rat. Health Physics
25 239-258 (Sept 1973)
If you are seeing this page full screen (i.e. without a navigation bar on the left) you can't see how the rest of the site is organised.
[BMA London: October 26, 1999]
[LLRC's first response]
We have now obtained the sequel to the paper1 cited by Dr Guthrie. This second
paper2 looked for Uranium concentrations and histological changes in animals up to five
years after the end of their exposure to inhaling Uranium Oxide (UO2) dust.
Lungs received such high doses that
The complete loss
of lymphoid tissue with replacement by pigment and fibrous tissue was characteristic of all
nodes in the tracheobronchial group from monkeys with post-exposure periods over 12
months.
pulmonary fibrosis seen in late post-
exposure monkeys had progressed to the point where severe impairment of respiratory
function, while not measured, must have occurred.
Tumours were found in none of the monkeys, but in dogs, whose accumulated
dose was roughly half that of the monkeys, pulmonary neoplasms were 50 - 100 times the
spontaneous (natural) rate. The discussion abstains from drawing conclusions. So do we,
with three exceptions.
Leach et al conclude:
1
The study confirms that uranium persists in TBLNs, with a biological half-life of
50 - 65 months in monkey TBLNs. An interesting observation, possibly relevant to DU, is
that in the lower dose monkeys (i.e. those exposed for one year rather than the full 5) the
TBLN burden continued to increase (by a factor of >3) throughout the 6 years of the post
exposure study.
2
Dr Guthrie's assertion that Part I of the inhalation study had shown no ill effects on
the subjects is not supported by Part II.
3
The paper notes that tumours occurred in the UO2 exposed dogs at estimated
alpha radiation doses one-fourth to one-fifth those producing the same response with
Plutonium 239. [i.e. in other studies] We suggest that this observation, which Leach et al
make in the context of speculating about the relationships between carcinogenic qualities
of different isotopes, undermines the conventional model of low dose radiation protection
and supports our contention that lower doses are disproportionately dangerous.
Pulmonary neoplasia developing after exposure to natural uranium
dust, even in a single species, is a sobering thought. The possibility
of this occurring in man under occupational conditions, however
remote, should be fully investigated. We cannot rely on animal
experiments alone to yield data that will answer this question,
therefore we believe that future investigations should be focused on
human exposures and post mortem data.
The Gulf War veterans are a potential "at risk" population big enough to give
statistically significant results. We note that the Ministry of Defence has now offered to
commission slightly more sensitive testing for Uranium in those veterans who have tested
positive in monitoring conducted at their own expense in Canada and the USA. This is
completely inadequate. MAP should be extended to all veterans.
References
This Home page link takes you to the index page, which has links to all the topics we discuss on the site [only use it if this page is full screen]
Use the Depleted Uranium button to see what else we have to say on this topic.
Send email to: SiteManager@llrc.org with questions or comments about this web site.